- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
Optimized Management of Nivolumab and Ipilimumab in Advanced Renal Cell Carcinoma: A Response-Based Phase II Study (OMNIVORE).
October 28, 2020
Suppressive effects of RASAL2 on renal cell carcinoma via SOX2/ERK/p38 MAPK pathway.
October 27, 2020
A risk stratification model based on four novel biomarkers predicts prognosis for patients with renal cell carcinoma.
October 27, 2020
Absorption of the orally active multikinase inhibitor axitinib as a therapeutic index to guide dose titration in metastatic renal cell carcinoma.
October 26, 2020
Transplant Radical Nephrectomy and Transplant Radical Nephroureterectomy for Renal Cancer: Postoperative and Survival Outcomes.
October 26, 2020
Dynamic 68Ga-PSMA-11 PET/CT for the primary evaluation of localized renal mass: a prospective study.
October 26, 2020
HIF1α is not a target of 14q deletion in clear cell renal cancer.
October 22, 2020
Folliculin deficient renal cancer cells exhibit BRCA1 A complex expression impairment and sensitivity to PARP1 inhibitor olaparib.
October 22, 2020
Robot-assisted retroperitoneal lymphadenectomy in patient with type I papillary renal cancer recurrence after 5 years of follow-up.
October 21, 2020
Cultivation of Clear Cell Renal Cell Carcinoma Patient-Derived Organoids in an Air-Liquid Interface System as a Tool for Studying Individualized Therapy.
October 21, 2020
Long Non-coding RNA CCAT1 Acts as an Oncogene and Promotes Sunitinib Resistance in Renal Cell Carcinoma.
October 21, 2020
Metastatic renal cell carcinoma to the pancreas: Clinical features and treatment outcome.
October 20, 2020
Circulating Non-coding RNAs in Renal Cell Carcinoma-Pathogenesis and Potential Implications as Clinical Biomarkers.
October 20, 2020
Association between copy-number alteration of +20q, -14q and -18p and cross-sensitivity to tyrosine kinase inhibitors in clear-cell renal cell carcinoma.
October 20, 2020